Does Nicotine Cause Cancer
Nicotine
& Cancer
Nicotine itself is not classified as a Group 1 carcinogen. Smoking causes cancer but through combustion by-products, not nicotine. Here is the full UK-aligned evidence picture.
Nicotine itself is not classified as a Group 1 carcinogen. Smoking unambiguously causes cancer but the cancer-causing chemicals come from combustion by-products (tar, 70+ identified carcinogens, thousands of chemicals formed when tobacco burns) rather than from nicotine. This distinction is why Public Health England plus OHID estimate vaping is around 95 per cent less harmful than smoking. Vaping heats without burning so most cancer-causing compounds are absent or present at vastly lower levels. Some research suggests nicotine may have tumour-promoting effects on existing cancers so people with cancer diagnoses should consult their oncology team. Vape is substantially lower cancer risk than smoking but is not risk-free.
Where cancer risk
actually comes from
Three figures that summarise the international classification of nicotine, the carcinogen count in cigarette smoke plus the UK public health position on relative harm.
Nicotine itself
Nicotine is not classified as a Group 1 carcinogen by WHO IARC. The classification reflects current evidence on direct cancer causation.
In cigarette smoke
Cigarette smoke contains at least 70 identified cancer-causing chemicals formed during combustion. None of these are in vape.
Vaping vs smoking
Public Health England plus OHID estimate reflecting the absence of combustion by-products in vape.
Nicotine is not carcinogenic. Combustion chemicals are.
Nicotine itself is not classified as a cancer-causing substance. Smoking unambiguously causes cancer but the cancer-causing chemicals come from tobacco combustion (tar, thousands of chemicals formed when tobacco burns) rather than nicotine itself. This is an important distinction because it explains why vaping is estimated to be substantially less harmful than smoking despite both delivering nicotine. Some research does suggest nicotine may have tumour-promoting effects on existing cancers so people with current cancer diagnoses should discuss nicotine use with their oncology team. Here is the full picture based on current UK plus international evidence. This article is general consumer information, not medical advice.
What the evidence says about nicotine and cancer
The most authoritative source on cancer causation is the International Agency for Research on Cancer (IARC) which is part of the World Health Organization. IARC classifies substances into four groups based on cancer-causing evidence:
- Group 1: Carcinogenic to humans. Strong evidence of cancer causation. Includes tobacco smoke, asbestos, alcohol plus many others.
- Group 2A: Probably carcinogenic. Limited human evidence but strong animal evidence.
- Group 2B: Possibly carcinogenic. Limited evidence overall.
- Group 3: Not classifiable. Insufficient evidence either way.
Tobacco smoking is classified Group 1 with overwhelming evidence. Nicotine itself is not classified as a carcinogen in any group. This distinction matters: the cancer risk from smoking comes from components of smoke other than nicotine.
What actually causes cancer in smoking
Cigarette smoke contains thousands of chemicals. At least 70 are classified as carcinogens by IARC. The main cancer-causing components include:
- Tar. Sticky residue that coats airways plus lungs. Contains many carcinogenic compounds.
- Polycyclic aromatic hydrocarbons (PAHs). Formed in any combustion. Classical carcinogens.
- Tobacco-specific nitrosamines. Particularly damaging compounds formed during tobacco processing plus combustion.
- Formaldehyde. Known carcinogen formed during combustion.
- Benzene. Known carcinogen. Present in tobacco smoke.
- Cadmium and other heavy metals. Carcinogenic plus accumulate in lung tissue over time.
- Dozens of other chemicals. Many with individual or combined cancer-causing effects.
These compounds are produced or released when tobacco burns. They are absent or present at vastly lower levels in compliant UK vape products. This is the mechanistic basis for the 95 per cent harm reduction estimate.
The vape cancer risk picture
Vape contains propylene glycol, vegetable glycerine, flavourings plus nicotine. Research on these components plus on vapour itself has identified some concerns but the picture is substantially different from smoking:
- No tar. The single largest cancer-causing component of cigarette smoke is absent.
- No combustion by-products. The hundreds of harmful chemicals formed by burning tobacco are not produced in vaping.
- Very low levels of carcinogens overall. Published analysis typically shows vape contains less than 1 per cent of the carcinogen levels in cigarette smoke.
- Some trace concerns remain. Certain flavour compounds at high heat plus some metal particles from coils have been studied. Levels are generally far below those in smoke.
Public Health England, OHID plus NHS consistently position vape as significantly lower cancer risk than smoking while noting that vape is not risk-free.
The tumour-promoting research
A nuance worth understanding: while nicotine is not tumour-initiating, some research suggests nicotine may have tumour-promoting effects on existing cancers. Proposed mechanisms include:
- Effects on angiogenesis (new blood vessel formation) which tumours need to grow.
- Modulation of immune response which normally helps control cancer cells.
- Effects on apoptosis (programmed cell death) which normally removes abnormal cells.
The research base on these effects is mixed plus largely from laboratory plus animal studies. Clinical significance in humans is debated. What this means practically:
- For people without cancer: nicotine is not considered cancer-causing.
- For people with current cancer: speak to your oncology team. NHS guidance typically favours nicotine cessation during active treatment.
- For cancer survivors: discuss with your GP or oncology follow-up team.
The UK public health position
UK public health bodies have consistently supported vape as a harm reduction tool since 2015. Key positions:
- Public Health England 2015 review. Estimated vaping was around 95 per cent less harmful than smoking. This estimate has been maintained across subsequent reviews.
- OHID continued position. The Office for Health Improvement and Disparities (which absorbed PHE functions) continues to support vape as a smoking cessation tool.
- NHS Stop Smoking Services. Actively recommend vape as one of the most effective quit aids.
- Swap to Stop programme. NHS England programme providing free vape kits to smokers.
- Cochrane Review 2024. Gold-standard evidence review confirmed vape effectiveness for smoking cessation plus the safety profile relative to continued smoking.
The UK position is unusually clear compared to some other countries where vape policy is more restrictive.
What this means for your risk
- If you are a smoker: switching to vape reduces cancer risk substantially over time. Quitting nicotine entirely is cleanest.
- If you are a vaper and not a smoker: cancer risk is substantially lower than smoking but not zero. The evidence base is still developing.
- If you are a non-nicotine user: starting vape introduces some risk that was not there before. NHS guidance says do not start.
- If you have a cancer diagnosis: discuss nicotine use with your oncology team. Guidance often favours cessation during treatment.
- If you have family history of cancer: general principle of minimising modifiable risks applies. Discuss with your GP.
For anyone stepping down nicotine strength toward cessation, our nicotine salts collection covers every UK compliant strength from 20mg down to 3mg.
The components that
cause cancer are not nicotine
Cigarette smoke contains thousands of chemicals. At least 70 are classified carcinogens. These are what drive smoking-related cancer risk. All are absent or negligible in vape.
Tar
Sticky residue with many carcinogenic compounds. Single largest cancer driver in smoke. Absent in vape.
Nitrosamines
Tobacco-specific carcinogens formed during processing plus combustion. Not present in compliant vape.
Combustion products
Formaldehyde, benzene, PAHs plus others formed when tobacco burns. Not produced in heated-not-burned vape.
Heavy metals
Cadmium plus others in tobacco smoke. Trace metals can appear in vape coils but levels are substantially lower.
What the evidence
actually says
Nicotine itself is not classified as carcinogenic
IARC does not list nicotine as a Group 1, 2A or 2B carcinogen. Cancer risk from smoking comes from other components.
Cancer comes from combustion
Burning tobacco produces tar plus thousands of chemicals. Vape heats without burning so most cancer-causing compounds are absent.
Vape is substantially lower cancer risk than smoking
PHE plus OHID estimate 95 per cent less harmful. The mechanistic case is strong but vape is not risk-free.
Cancer patients should consult oncology team
Some research suggests nicotine may promote existing cancers. NHS guidance typically favours cessation during treatment.
Shop the nicotine salts range
Our nicotine salts collection covers every UK compliant strength from 20mg down to 3mg. Stepping down over time as part of a longer-term quit plan reduces cumulative exposure. Free next-day delivery on orders over £20.
Choices that reduce
vs raise cancer risk
Several lifestyle choices meaningfully affect cancer risk. Here is the direct side by side of choices that reduce versus raise risk in the nicotine plus cancer context.
Risk-reducing choices
- ✓Quitting smoking if currently smoking single largest cancer risk reduction.
- ✓Switching from smoking to vaping if complete cessation not working.
- ✓Stepping down nicotine strength over time.
- ✓Oncology team consultation for cancer patients about nicotine use.
- ✓Discussing family history with GP for personalised risk picture.
- ✓Regular health checks for early detection of any issues.
Risk-raising choices
- ✗Continuing to smoke substantial and documented cancer risk.
- ✗Starting vape as a non-smoker introduces risk without offsetting benefit.
- ✗Vaping during active cancer treatment without oncology team guidance.
- ✗Assuming vape is risk-free research base still developing.
- ✗Hiding nicotine use from medical team affects treatment planning.
- ✗Ignoring persistent cough or other symptoms that warrant investigation.
For the wider view on vape, smoking comparison plus harm reduction evidence, our full health hub covers every major question UK readers ask.
Back to the Prefilled Pod Systems guide
This article is one chapter inside our complete Prefilled Pod Systems knowledge base. Head back to the hub for the full index covering refilling, safety, longevity plus regulation.
More on vape & smoking harm comparison
For the broader long-term comparison between vape and smoking, our piece on is long term vaping safer than long term smoking walks through the evidence. For the general harm reduction framework from UK public health, how vaping compares to smoking for harm reduction covers it. And for the medical professional perspective, what doctors say about vaping as a smoking alternative covers clinician views.